214 related articles for article (PubMed ID: 32089472)
1. Has Stage Migration in Renal Cancer Run Its Course? A SEER Database Analysis.
Haifler M; Neheman A; Zisman A
Clin Genitourin Cancer; 2020 Aug; 18(4):e368-e373. PubMed ID: 32089472
[TBL] [Abstract][Full Text] [Related]
2. Trends in Renal-Cell Carcinoma Incidence and Mortality in the United States in the Last 2 Decades: A SEER-Based Study.
Saad AM; Gad MM; Al-Husseini MJ; Ruhban IA; Sonbol MB; Ho TH
Clin Genitourin Cancer; 2019 Feb; 17(1):46-57.e5. PubMed ID: 30391138
[TBL] [Abstract][Full Text] [Related]
3. Recent trends in incidence, mortality, survival, and treatment of upper tract urothelial carcinoma.
Ma Z; Yi Y; Qiu Z
Fr J Urol; 2024 Mar; 34(2):102573. PubMed ID: 38330829
[TBL] [Abstract][Full Text] [Related]
4. Rising incidence of small renal masses: a need to reassess treatment effect.
Hollingsworth JM; Miller DC; Daignault S; Hollenbeck BK
J Natl Cancer Inst; 2006 Sep; 98(18):1331-4. PubMed ID: 16985252
[TBL] [Abstract][Full Text] [Related]
5. Continued increase in incidence of renal cell carcinoma, especially in young patients and high grade disease: United States 2001 to 2010.
King SC; Pollack LA; Li J; King JB; Master VA
J Urol; 2014 Jun; 191(6):1665-70. PubMed ID: 24423441
[TBL] [Abstract][Full Text] [Related]
6. Age-adjusted incidence, mortality, and survival rates of stage-specific renal cell carcinoma in North America: a trend analysis.
Sun M; Thuret R; Abdollah F; Lughezzani G; Schmitges J; Tian Z; Shariat SF; Montorsi F; Patard JJ; Perrotte P; Karakiewicz PI
Eur Urol; 2011 Jan; 59(1):135-41. PubMed ID: 21035250
[TBL] [Abstract][Full Text] [Related]
7. Increasing incidence of all stages of kidney cancer in the last 2 decades in the United States: an analysis of surveillance, epidemiology and end results program data.
Hock LM; Lynch J; Balaji KC
J Urol; 2002 Jan; 167(1):57-60. PubMed ID: 11743275
[TBL] [Abstract][Full Text] [Related]
8. Rising incidence of renal cell cancer in the United States.
Chow WH; Devesa SS; Warren JL; Fraumeni JF
JAMA; 1999 May; 281(17):1628-31. PubMed ID: 10235157
[TBL] [Abstract][Full Text] [Related]
9. Age, tumor size and relative survival of patients with localized renal cell carcinoma: a surveillance, epidemiology and end results analysis.
Scoll BJ; Wong YN; Egleston BL; Kunkle DA; Saad IR; Uzzo RG
J Urol; 2009 Feb; 181(2):506-11. PubMed ID: 19084868
[TBL] [Abstract][Full Text] [Related]
10. Racial disparity in incidence patterns and outcome of kidney cancer.
Vaishampayan UN; Do H; Hussain M; Schwartz K
Urology; 2003 Dec; 62(6):1012-7. PubMed ID: 14665346
[TBL] [Abstract][Full Text] [Related]
11. Trends in the incidence and survival of patients with esophageal cancer: A SEER database analysis.
He H; Chen N; Hou Y; Wang Z; Zhang Y; Zhang G; Fu J
Thorac Cancer; 2020 May; 11(5):1121-1128. PubMed ID: 32154652
[TBL] [Abstract][Full Text] [Related]
12. Plasma Cell Myeloma - 20-Year Comparative Survival and Mortality of Three Plasma Cell Myeloma ICD-O-3 Oncologic Phenotypes by Age, Sex, Race, Stage, Cohort Entry Time-Period and Disease Duration: A Systematic Review of 111,041 Cases for Diagnosis Years 1973-2014: (SEER*Stat 8.3.4).
Milano AF
J Insur Med; 2018; 47(4):203-211. PubMed ID: 30668210
[TBL] [Abstract][Full Text] [Related]
13. Rates and trends in stage-specific prostate cancer incidence by age and race/ethnicity, 2000-2017.
Cao Y; Zhang W; Li Y; Fu J; Li H; Li X; Gao X; Zhang K; Liu S
Prostate; 2021 Oct; 81(14):1071-1077. PubMed ID: 34320230
[TBL] [Abstract][Full Text] [Related]
14. Contemporary incidence and mortality rates of kidney cancer in the United States.
Gandaglia G; Ravi P; Abdollah F; Abd-El-Barr AE; Becker A; Popa I; Briganti A; Karakiewicz PI; Trinh QD; Jewett MA; Sun M
Can Urol Assoc J; 2014 Jul; 8(7-8):247-52. PubMed ID: 25210548
[TBL] [Abstract][Full Text] [Related]
15. Italian cancer figures, report 2012: Cancer in children and adolescents.
; ;
Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
[TBL] [Abstract][Full Text] [Related]
16. A population-based competing-risks analysis of survival after nephrectomy for renal cell carcinoma.
Bianchi M; Gandaglia G; Trinh QD; Hansen J; Becker A; Abdollah F; Tian Z; Lughezzani G; Roghmann F; Briganti A; Montorsi F; Karakiewicz PI; Sun M
Urol Oncol; 2014 Jan; 32(1):46.e1-7. PubMed ID: 24054864
[TBL] [Abstract][Full Text] [Related]
17. Clinical Stage Migration and Survival for Renal Cell Carcinoma in the United States.
Patel HD; Gupta M; Joice GA; Srivastava A; Alam R; Allaf ME; Pierorazio PM
Eur Urol Oncol; 2019 Jul; 2(4):343-348. PubMed ID: 31277771
[TBL] [Abstract][Full Text] [Related]
18. Trends in Thyroid Cancer Incidence and Mortality in the United States, 1974-2013.
Lim H; Devesa SS; Sosa JA; Check D; Kitahara CM
JAMA; 2017 Apr; 317(13):1338-1348. PubMed ID: 28362912
[TBL] [Abstract][Full Text] [Related]
19. Impact of gender in renal cell carcinoma: an analysis of the SEER database.
Aron M; Nguyen MM; Stein RJ; Gill IS
Eur Urol; 2008 Jul; 54(1):133-40. PubMed ID: 18160207
[TBL] [Abstract][Full Text] [Related]
20. Incidence, survival and mortality rates of stage-specific bladder cancer in United States: a trend analysis.
Abdollah F; Gandaglia G; Thuret R; Schmitges J; Tian Z; Jeldres C; Passoni NM; Briganti A; Shariat SF; Perrotte P; Montorsi F; Karakiewicz PI; Sun M
Cancer Epidemiol; 2013 Jun; 37(3):219-25. PubMed ID: 23485480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]